• Cl-Amidine trifluoroacetate salt: Dissecting PAD4 Inhibit...

  2025-10-20

  Explore how Cl-Amidine trifluoroacetate salt, a potent PAD4 deimination activity inhibitor, is transforming the study of neutrophil extracellular traps (NETs) and epigenetic regulation in cancer and inflammatory disease. This article delivers a distinct, mechanistic perspective on PAD4 inhibition, linking advanced disease modeling with translational research.

• I-BET-762: Advanced Mechanistic Insights and Translationa...

  2025-10-19

  Explore I-BET-762, a potent BET inhibitor, as an epigenetic regulation inhibitor and anti-inflammatory agent in preclinical models. This article delivers a novel, mechanistic perspective on transcriptional regulation and ferroptosis, highlighting unique translational strategies for BET protein signaling pathway research.

• Cl-Amidine Trifluoroacetate Salt: Precision PAD4 Inhibiti...

  2025-10-18

  Cl-Amidine (trifluoroacetate salt) stands out as a next-generation, highly selective PAD4 deimination activity inhibitor, uniquely empowering epigenetic, cancer, and immune research. This guide delivers actionable workflows and troubleshooting strategies, revealing how Cl-Amidine enables reproducible, high-impact data generation in complex disease models.

• Strategic Modulation of Apoptotic and Non-Apoptotic Cell ...

  2025-10-17

  This thought-leadership article equips translational researchers with a mechanistic and strategic roadmap for leveraging Z-DEVD-FMK—a potent, cell-permeable, irreversible caspase-3 inhibitor with dual calpain inhibitory activity—to dissect, modulate, and innovate within cell death pathways. Framing the evolving landscape of apoptosis and necrosis research, we analyze the biological rationale for targeting caspases and calpain, validate experimental approaches, assess competitive differentiators, and project future directions for clinical translation in neurodegeneration and oncology. By synthesizing emerging evidence, including new insights into caspase signaling in cancer, this article delivers actionable guidance and uniquely positions Z-DEVD-FMK as a cornerstone for next-generation discovery.

• Berberine: AMPK Activator for Metabolic & Inflammation Re...

  2025-10-16

  Berberine (CAS 2086-83-1) is a benchmark isoquinoline alkaloid for metabolic disease research, renowned for its dual action as an AMPK activator and inflammation regulator. This guide details advanced experimental workflows, troubleshooting strategies, and translational use-cases, providing actionable insights for scientists modeling diabetes, obesity, and cardiovascular disorders.

• Our published data showed that in mouse heart

  2023-07-06

  

  Our published data showed that, in mouse heart, the protein level of WDR1 was highest during the embryonic stage, but became progressively decreased to a constant level from birth to adulthood (Yuan et al., 2014), indicating an important role of WDR1 in embryonic heart development. However, function

• br Conflict of interest br Acknowledgments This work was bee

  2023-07-05

  

  Conflict of interest Acknowledgments This work was been partially supported by the following grants: C.I.S.I.A. project (Innovazione e Sviluppo del Mezzogiorno—Conoscenze Integrate per Sostenibilità ed Innovazione del Made in Italy Agroalimentare—Legge 191/2009) from the Italian Ministry of Ec

• BAY 61-3606 sale PD research involves the use of many

  2023-07-05

  

  PD research involves the use of many animal models, which can be categorized into two main types: toxic models—among which the two most widely used are the classical 6-hydroxydopamine (6-OHDA) model in rats and the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model in mice and monkeys—and gen

• br Experimental procedures br Results br Discussion

  2023-07-05

  

  Experimental procedures Results Discussion Although previous studies have indicated that astrocyte aromatase plays a role in nociceptive processes (O'Brien et al., 2015, Smeester et al., 2016), the mechanisms responsible for the regulation of aromatase and its involvement in nociception rem

• Evidence from basic science studies suggests that Cd

  2023-07-05

  

  Evidence from basic science studies suggests that Cd may play a role in prostate cancer through disruption of the androgen receptor (AR). AR, a hormone-activated transcription factor, is the key driver of prostate cancer progression [6]. Ironically, the AR is also required for normal prostate growth

• br Conclus o br Conflitos de interesses br Alzheimer Disease

  2023-07-05

  

  Conclusão Conflitos de interesses Alzheimer Disease: Common and Complex Alzheimer’s disease (AD) is a genetically complex, multifactorial disease that leads to neurodegenerative dementia. There is no cure for AD yet, and due to a high prevalence and continuously increasing incidence it pose

• br Materials and methods br Results br Discussion

  2023-07-05

  

  Materials and methods Results Discussion Wound healing of the human cornea is a complex process that requires cell migration and proliferation. Corneal wound healing is characterized by major changes in the composition of the ECM such as a massive transitory secretion of fibronectin combine

• br Materials and methods br Results br Discussion

  2023-07-05

  

  Materials and methods Results Discussion Wound healing of the human cornea is a complex process that requires cell migration and proliferation. Corneal wound healing is characterized by major changes in the composition of the ECM such as a massive transitory secretion of fibronectin combine

• The inflammatory cytokine IL is an additional factor

  2023-07-05

  

  The inflammatory cytokine IL-6 is an additional factor that has been hypothesized to contribute to epinephrine-mediated repression of drug detoxifying proteins such as CYP3A4 (Aninat et al., 2008). Indeed, this CYP is well-known to be repressed by IL-6 (Dickmann et al., 2011) and epinephrine has pre

• The disease stimulatory effects of hyperadiponectinemia in p

  2023-07-05

  

  The disease-stimulatory effects of hyperadiponectinemia in patients contradict a previous view based on studies of preclinical models showing that APN might be beneficial for AD [8]. Indeed, despite the action of APN as a risk factor in patients with AD, APN is protective against oxidative stress-in

11301 records 9/754 page Previous Next First page 上5页 678910 下5页 Last page